Chemical Compound

(2S)-N-[(2S,3R)-4-{[(8S,11S)-8-(Butan-2-yl)-7,10-dihydroxy-2-oxa-6,9-diazabicyclo[11.2.2]heptadeca-1(15),6,9,13,16-pentaen-11-yl]amino}-3-hydroxy-1-(4-hydroxyphenyl)butan-2-yl]-3-methyl-2-(2-oxopyrrolidin-1-yl)butanimidic acid

CAS Registry Number 180968-27-8
(2S)-N-[(2S,3R)-4-{[(8S,11S)-8-(Butan-2-yl)-7,10-dihydroxy-2-oxa-6,9-diazabicyclo[11.2.2]heptadeca-1(15),6,9,13,16-pentaen-11-yl]amino}-3-hydroxy-1-(4-hydroxyphenyl)butan-2-yl]-3-methyl-2-(2-oxopyrrolidin-1-yl)butanimidic acid 结构式
Primary record

(2S)-N-[(2S,3R)-4-{[(8S,11S)-8-(Butan-2-yl)-7,10-dihydroxy-2-oxa-6,9-diazabicyclo[11.2.2]heptadeca-1(15),6,9,13,16-pentaen-11-yl]amino}-3-hydroxy-1-(4-hydroxyphenyl)butan-2-yl]-3-methyl-2-(2-oxopyrrolidin-1-yl)butanimidic acid

库存
4,758 克
纯度
99.5 %
CAS
180968-27-8

化合物标识与属性

CAS
180968-27-8
PubChem CID
461280
SMILES
CCC(C)[C@H]1C(=O)NCCCOC2=CC=C(C[C@@H](C(=O)N1)NC[C@H]([C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](C(C)C)N4CCCC4=O)O)C=C2
Canonical SMILES
CCC(C)[C@@H]1NC(=O)[C@@H](NC[C@@H](O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(C)C)N2CCCC2=O)Cc2ccc(cc2)OCCCNC1=O

名称与同义词

  • AC1LA3YL
  • Peptidomimetic inhibitor 5
  • BDBM13931
  • DTXSID50939396
  • AIDS080637
  • CID461280
  • MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 5
  • 180968-27-8
  • 1OH-2(Cbz-ValNH)3PhPr [13]paracyclophane deriv.
  • (1'S,2'S,2''S,9S,11R)-11-(2''-((N-((Benzyloxy)carbonyl)valyl)amino)-1'-hydroxy-3'-phenylprop-1'-yl)-8-(1-methylethyl)-6,9,12-triaza-1-oxa-7,10-dioxo(13)paracyclophane
  • (2S)-N-[(1S,2R)-3-[[(3S,6S)-4,7-dioxo-6-sec-butyl-12-oxa-5,8-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-3-yl]amino]-2-hydroxy-1-[(4-hydroxyphenyl)methyl]propyl]-3-methyl-2-(2-oxopyrrolidin-1-yl)butanamide
  • (1'S,2'S,2"S,9S,11R)-11-(2"-((N-((Benzyloxy)carbonyl)valyl)amino)-1'-hydroxy-3'-phenylprop-1'-yl)-8-(1-methylethyl)-6,9,12-triaza-1-oxa-7,10-dioxo(13)paracyclophane
  • (1'S,2'S,2"S,9S,11R)-11-[2"-[[N-[(Benzyloxy)carbonyl]valyl]amino]-1'-hydroxy-3'-phenylprop-1'-yl]-8-(1-methylethyl)-6,9,12-triaza-1-oxa-7,10-dioxo[13]paracyclophane
  • (2S)-N-[(2S,3R)-4-[[(3S,6S)-6-butan-2-yl-4,7-dioxo-12-oxa-5,8-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-3-yl]amino]-3-hydroxy-1-(4-hydroxyphenyl)butan-2-yl]-3-methyl-2-(2-oxopyrrolidin-1-yl)butanamide
  • (2S)-N-[(2S,3R)-4-{[(8S,11S)-8-(Butan-2-yl)-7,10-dihydroxy-2-oxa-6,9-diazabicyclo[11.2.2]heptadeca-1(15),6,9,13,16-pentaen-11-yl]amino}-3-hydroxy-1-(4-hydroxyphenyl)butan-2-yl]-3-methyl-2-(2-oxopyrrolidin-1-yl)butanimidic acid
  • (2S)-N-[(2S,3R)-4-{[(8S,11S)-8-[(2R)-butan-2-yl]-7,10-dioxo-2-oxa-6,9-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-yl]amino}-3-hydroxy-1-(4-hydroxyphenyl)butan-2-yl]-3-methyl-2-(2-oxopyrrolidin-1-yl)butanamide
  • (S)-N-[(1S,2R)-3-((8S,11S)-8-sec-Butyl-7,10-dioxo-2-oxa-6,9-diaza-bicyclo[11.2.2]heptadeca-1(16),13(17),14-trien-11-ylamino)-2-hydroxy-1-(4-hydroxy-benzyl)-propyl]-3-methyl-2-(2-oxo-pyrrolidin-1-yl)-butyramide
  • N-[4-{[8-(Butan-2-yl)-7,10-dihydroxy-2-oxa-6,9-diazabicyclo[11.2.2]heptadeca-1(15),6,9,13,16-pentaen-11-yl]amino}-3-hydroxy-1-(4-hydroxyphenyl)butan-2-yl]-3-methyl-2-(2-oxopyrrolidin-1-yl)butanimidic acid